Skip to content

Evogene Ltd.

EVGN

CIK 0001574565 · Agricultural Chemicals · Nasdaq

← back to feed
Revenue (TTM)
$3.85M
−30.9% YoY FY Dec 2025
Net Income (TTM)
−$7.83M
+56.6% YoY FY Dec 2025
EPS Diluted (TTM)
$1.08
+137.2% YoY FY Dec 2025
Gross Margin
-6.3%
FY Dec 2025
Operating Margin
-364.2%
FY Dec 2025
Net Margin
-203.1%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
$12.96M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
8.72M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings